Morgan Stanley downgrades Zscaler stock rating on platform concerns

Morgan Stanley downgraded Zscaler to Equalweight from Overweight and cut its price target to $155 from $200, citing slower traction in Red Canary, mid-teens growth in ZIA/ZPA, and rising competitive pressure. The firm still sees Zscaler as a category leader in Zero Trust and SASE, but warned that elongated sales cycles and pricing competition could make sustaining 20%+ growth harder as the market matures. The stock is already down more than 35% year-to-date, even as recent results beat estimates and guidance was raised.

Analysis

The core issue is not the headline downgrade; it is that the market is moving from a “platform optionality” multiple to a proof-of-consumption multiple. Zscaler can still compound, but the valuation deserves less credit if the next leg of growth depends on stitching acquisitions into the core rather than expanding naturally within the installed base. In other words, the stock is now being judged on whether it can defend mid-teens organic growth in a maturing category while integration is still a forward story.

The second-order loser is the broader SASE basket: as large enterprises move from greenfield to brownfield, win rates tend to become more contingent on network adjacency, bundle economics, and procurement leverage. That usually benefits incumbents with broader IT estates and a weaker standalone moat for pure plays; the pressure may show up first in deal cycle elongation, then in discounting, then in slower net new ARR. If this pattern holds, the market will likely re-rate the entire security infrastructure cohort, not just ZS, with multiple compression spreading to names perceived as “next platform” aspirants.

The near-term catalyst is not revenue surprise but tone on pipeline durability, especially around large enterprise and cross-sell conversion over the next 1-2 quarters. The contrarian view is that consensus may be over-anchored to the weakness in headline price target cuts while underestimating the quality of reported execution: strong free cash flow, resilient guidance, and partner feedback can keep the stock from cascading lower if management proves Red Canary is accretive sooner than feared. The risk/reward skews better for tactical shorts on rallies than for outright chasing downside after a large year-to-date drawdown.

Key Decisions for Investors

• Tactically short ZS into strength over the next 2-6 weeks; use a rally toward prior support as the entry, targeting a 10-15% downside move if management commentary confirms elongated enterprise cycles and slower Red Canary attach.
• If already long, reduce ZS to a market-weight position and finance downside protection with a 3-6 month put spread; the implied risk is multiple compression, not a complete fundamentals break.
• Pair trade: long broader platform vendors with network adjacency vs. short ZS over the next 1-2 quarters, expressing the thesis that brownfield SASE favors bundlers over standalone specialists.
• Avoid adding to the cybersecurity beta basket on “strong quarter” headlines until we see evidence of accelerating large-deal conversion; the better entry is after the next guidance reset or post-earnings volatility.
• For longer-duration portfolios, monitor ZS only if the market begins to price Red Canary as a 2027 growth driver; otherwise, treat any bounce as a mean-reversion trade rather than a new compounding leg.